Position in TGTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$73,839
New position
Shares Held
1,344
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#337
of 425 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026USA FINANCIAL FORMULAS holds $832,916 across 7 Biotechnology names. TGTX ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
4,439 | $248,894 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,008 | $242,897 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
269 | $99,979 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
1,344 | $73,839 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
743 | $58,154 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,054 | $57,348 | |
| 7 | INCY |
Incyte Corp
|
457 | $51,805 |
All Filings in TGTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,839 | 1,344 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||